Clinical Trial

Lacripep for Corneal Wound Healing Study

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate the safety and effectiveness of Lacripep as a therapy for superficial corneal injury repair after Photorefractive keratectomy (PRK).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-02-25; most recent amendment 2026-03-24.
Status change: Not Yet Recruiting → Recruiting 2025-07-01
Trial Details
NCT Number NCT06854393
Lead Sponsor Henry M. Jackson Foundation for the Advancement of Military Medicine
Collaborators: TearSolutions, Inc., Walter Reed National Military Medical Center
Conditions Corneal Epithelial Wound Healing
Enrollment 88 participants
Start Date 2025-05-23
Primary Completion 2027-06 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-03-25